Loading…
← CockpitCompetitor Analysis › 5889.T Japan Eyewear Holdings Co.,Ltd.Open in the cockpit ↗

Japan Eyewear Holdings Co.,Ltd.5889.TCompetitor analysis, valuation and peers

Japan · JPY·Health Care›Medical Specialties
Momentum weak 24
Mkt cap
$318M
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$1.82M
20-day average traded
Fwd P/E
10.7×
forward earnings
ROIC−WACC
+9.2 pp
WACC 5.0%
Hurdle
-30 pp
Req g minus delivered
Next earnings
23 days
11 Dec 2026
Close · JPY¥2,072
1D-2.6%
1W-7.2%
1M-6.7%
3M-20.6%
6M-5.5%
YTD+2.1%
1Y+3.8%
ATR %3.3%
52w lowhigh24.2% off high

What Japan Eyewear does

Employees: 637

Japan Eyewear at a glance

Size Japan Eyewear (5889.T) is a Japan Health Care company (Medical Specialties) with a market value of $318M, the 1323rd largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥2,072 on 18 Nov 2026.

Performance Over six months the shares fell 5.5%, against -20.4% for the median peer and -1.4% for the Japan market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 15.4% over the last twelve months (peer median +2.2%); the operating margin is 32.4% (peer median 7.9%).

Valuation It trades at 10.7× forward earnings against a peer median of 17.8× (2nd cheapest of 13).

Price implies For today's price to make sense, revenue must grow about -9% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -30 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 9.2 points above its cost of capital (5.0% WACC).

Next results Next results expected around 11 Dec 2026 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 20265889.T 97Peer median 80
Six months, rebased to 100: Japan Eyewear against the median of its 20 peers (local-currency closes).

Japan Eyewear financials

Reported figures in JPY; fiscal year ends 2026-01-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥20.0B¥18.6B¥16.7B¥13.5B¥10.7B
Revenue growth—+12%+23%+26%—
Gross profit¥15.7B¥14.7B¥13.1B¥10.5B¥8.21B
EBITDA¥8.46B¥7.86B¥7.00B¥5.28B¥3.62B
Net income¥4.28B¥3.78B¥3.99B¥2.22B¥293M
Free cash flow¥5.50B¥4.64B¥3.08B¥2.67B¥2.62B
Capital expenditure¥353M¥721M¥2.18B¥773M¥320M
Total debt¥15.8B¥15.6B¥16.6B¥16.5B¥17.1B

Quarterly statements and history in the cockpit →

Japan Eyewear competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-10%0%300942300753197A688576301502SMTI377740688273CLTN9996YDESEMBC688314VBSN3006536883381609SBSCV5889.T6-month return →1-month return →
Up and to the right = strong over both horizons. Japan Eyewear is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%0×250×500×750×300753197A688576SMTI377740688273CLTN9996EMBC3006535889.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Japan Eyewear is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-25%0%25%50%300753688468301502SMTI377740688273CLTNEMBC688314VBSN30065368833816095889.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Japan Eyewear is the large dot.

Japan Eyewear competitors and peer comparison

How Japan Eyewear compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Japan Eyewear against its 20 peers (data as of 18 Nov 2026)
Measure5889.TPeer medianRank in peer set
1-month return-6.7%-10.9%10th highest of 21
6-month return-5.5%-20.4%8th highest of 21
Distance from 52-week high-24.2%-48.0%6th highest of 21
Revenue growth (TTM)+15.4%+2.2%4th highest of 21
Operating margin32.4%7.9%2nd highest of 21
Forward P/E10.7×17.8×2nd cheapest of 13
Growth the price implies (Req g, 7 yrs)-9.4%10.7%5th least demanding of 15
Growth delivered (Del g)+20.2%+0.2%3rd highest of 15
Hurdle (Req g minus delivered)-29.7 pp+7.9 pp2nd least demanding of 15
ROIC minus cost of capital+9.2 pp+0.6 pp7th highest of 19
EV / EBITDA7.4×8.9×4th cheapest of 10
Net debt / EBITDA1.4×1.3×5th most indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Japan Eyewear 5889.TJapan$318M-5%+15%32%10.7×-9.4%+20.2%
Shenzhen Bioeasy Biotechnology 300942.SZChina$326M-27%+12%-2%n/an/an/a
Jiangsu Apon Medical Technology 300753.SZChina$326M-34%-15%-10%862.0×20.0%-5.1%
Chemclin Diagnostics 688468.SSChina$327M-24%-10%4%n/a15.8%-4.5%
Tauns Laboratories 197A.TJapan$327M-3%+7%29%16.7×n/an/a
Chongqing Xishan Science and Technology 688576.SSChina$301M-40%-23%-29%12.8×n/an/a
Jiangsu Huayang Intelligent Equipment 301502.SZChina$336M-36%-5%2%n/a34.3%+0.4%
Sanara MedTech SMTIUnited States$301M+42%+10%11%59.0×19.5%+45.9%
BioNote 377740.KSSouth Korea$337M-14%+12%18%14.4×-15.0%-28.5%
Nanjing Medlander Medical Technology 688273.SSChina$337M-47%-12%8%17.5×35.3%+5.2%
COLTENE CLTN.SWSwitzerland$339M-7%-2%8%25.2×-0.3%-0.7%
Peijia Medical 9996.HKHong Kong$296M-34%+21%-13%292.4×n/an/a
YD Bio YDESUnited States$344M+7%+17%-883%n/an/an/a
Embecta EMBCUnited States$345M+99%-8%26%3.8×-19.9%-0.1%
Kontour (Xi'an) Medical Technology 688314.SSChina$291M-46%+8%24%n/a3.1%+16.4%
IVF HARTMANN VBSN.SWSwitzerland$352M-2%+7%14%n/a-12.7%-1.3%
Yantai Zhenghai Bio-Tech 300653.SZChina$354M-23%-8%17%36.0×18.4%+4.4%
Beijing Succeeder Technology 688338.SSChina$362M-18%-4%31%16.4×5.7%+3.4%
Star Sports Medicine 1609.HKHong Kong$364M-73%+23%37%n/a-13.1%+36.8%
Stratec SBS.DEGermany$365M+63%-6%4%18.2×19.1%+0.1%
CapsoVision CVUnited States$366M+5%+15%-213%n/an/an/a

Questions

Which companies are Japan Eyewear's closest peers?
The cockpit's peer set: Shenzhen Bioeasy Biotechnology (300942.SZ), Jiangsu Apon Medical Technology (300753.SZ), Chemclin Diagnostics (688468.SS), Tauns Laboratories (197A.T), Chongqing Xishan Science and Technology (688576.SS), Jiangsu Huayang Intelligent Equipment (301502.SZ), Sanara MedTech (SMTI), BioNote (377740.KS).
Is Japan Eyewear expensive compared with its peers?
On forward p/e it trades at 10.7× against a peer median of 17.8×, 2nd cheapest of 13 in its peer set. For today's price to make sense, revenue must grow about -9% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -30 pp: the price already allows for a slowdown.
How has Japan Eyewear stock performed?
Over six months to 18 Nov 2026 the shares returned -5.5% against -20.4% for the median peer; over one year +3.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.